Comparison of Adherence to the 2013 ACC/AHA Cholesterol Guideline in a Teaching Versus Nonteaching Outpatient Clinic

Angela Cheng-Lai, Jessica Snead, Christina Ng, Caroline Verges, Philip Chung

Research output: Contribution to journalArticle

2 Scopus citations


Background: Little information is available regarding prescribers’ adherence rate to the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline, especially that from a teaching versus a nonteaching setting. Objectives: We aim to evaluate adherence rates to the 2013 ACC/AHA cholesterol guideline in a teaching versus a nonteaching practice site. In addition, the impact of a pharmacist-led seminar on adherence rate to the guideline was assessed. Methods: This study is a 2-part retrospective chart review. Part 1 consists of patients who were initiated on statin therapy between December 2013 and November 2014. Patients were analyzed to determine if they received concordant statin therapy as recommended by the guideline. For the second part, we evaluated the impact of a seminar on the adherence rate to the guideline. Results: Of the 325 patients who received a statin prescription, 233 were included in the study. Prescriber adherence to the guideline was 42.9%, which was significantly lower than the 65.8% observed in a study previously conducted at a teaching outpatient clinic (P < 0.0001). For the second part of our study, prescriber adherence to the guideline 3 months before the pharmacist-led seminar was 53.5%, and this adherence rate remained virtually unchanged at 54.2% at 3 months after the educational session. Conclusion: The overall adherence rate to the 2013 ACC/AHA cholesterol guideline from this nonteaching outpatient clinic was significantly lower than that previously observed in a teaching outpatient clinic. The single pharmacist-led seminar did not significantly affect prescribers’ adherence rate to the guideline.

Original languageEnglish (US)
Pages (from-to)338-344
Number of pages7
JournalAnnals of Pharmacotherapy
Issue number4
StatePublished - Apr 1 2018



  • HMG-CoA reductase inhibitors
  • atherosclerotic cardiovascular disease
  • cardiovascular drugs
  • cholesterol
  • clinical practice guidelines
  • coronary heart disease
  • evidence-based medicine
  • guideline adherence
  • hypercholesterolemia
  • hyperlipidemia
  • statins

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this